Alexander Tate Lasher

Alexander Tate Lasher

Auto-generated profile, based on publicly available information

Alexander Tate Lasher

Department of Biology, University of Alabama at Birmingham

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2023 in Aging Cell
Verified
Journal Article
Open access
HSHemant Srivastava
Hemant Srivastava
ALAlexander Tate Lasher
Alexander Tate Lasher
ANAkash Nagarajan
Akash Nagarajan
LSLiou Y. Sun
Liou Y. Sun
Alzheimer's disease (AD), a prevalent form of dementia, is characterized by the decline of cognitive abilities with age. Available treatment options for AD are limited, making it a significant public health concern. Recent research suggests that metabolic dysfunction plays a role in the development of AD. In addition, insulin therapy has been shown to improve memory in patients with cognitive decline. In this study, we report the first examination of body composition, peripheral insulin sensitivity, and glucose tolerance in relation to behavioral assessments of learning, memory, and anxiety in the TgF344‐AD rat model of AD. Results from glucose and insulin tolerance tests show that female TgF344‐AD rats exhibit impaired glucose clearance and reduced insulin sensitivity at both 9 and 12 months of age, while males display no differences at 9 months and even improved glucose clearance at 12 months. Results from the Morris Water Maze assessment of learning and memory reveal that male TgF344‐AD rats display impairments at both 9 and 12 months of age, while female TgF344‐AD rats only show impairments at 12 months. Furthermore, results from open field and elevated plus maze tests suggest that female TgF344‐AD rats display increased anxiety at 9 months of age; however, no differences were detected in males or at 12 months of age. Overall, our findings suggest that impairments in metabolism, commonly associated with type 2 diabetes, occur before or simultaneously with cognitive decline and anxiety in a sexually dimorphic manner in the TgF344‐AD rat model.

26 January 2024 in Aging Cell
Verified
Journal Article
Open access
ANAkash Nagarajan
Akash Nagarajan
ALAlexander Tate Lasher
Alexander Tate Lasher
CMCasey D. Morrow
Casey D. Morrow
LSLiou Y. Sun
Liou Y. Sun
The Methionine restriction (MR) diet has been shown to delay aging and extend lifespan in various model organisms. However, the long‐term effects of MR diet on the gut microbiome composition remain unclear. To study this, male mice were started on MR and control diet regimens at 6 months and continued until 22 months of age. MR mice have reduced body weight, fat mass percentage, and bone mineral density while having increased lean mass percentage. MR mice also have increased insulin sensitivity along with increasing indirect calorimetry markers such as energy expenditure, oxygen consumption, carbon dioxide production, and glucose oxidation. Fecal samples were collected at 1 week, 18 weeks, and 57 weeks after the diet onset for 16S rRNA amplicon sequencing to study the gut microbiome composition. Alpha and beta diversity metrics detected changes occurring due to the timepoint variable, but no changes were detected due to the diet variable. The results from LEfSe analysis surprisingly showed that more bacterial taxa changes were linked to age rather than diet. Interestingly, we found that the long‐term MR diet feeding induced smaller changes compared to short‐term feeding. Specific taxa changes due to the diet were observed at the 1 or 18‐week time points, including Ileibacterium, Odoribacter, Lachnoclostridium, Marinifilaceae, and Lactobacillaceae. Furthermore, there were consistent aging‐associated changes across both groups, with an increase in Ileibacterium and Erysipelotrichaceae with age, while Eubacterium_coprostanoligenes_group, Ruminococcaceae, Peptococcaceae, and Peptococcus decreased with age.

12 June 2024 in Aging Cell
Verified
Journal Article
Open access
JAJoseph Adkins‐Jablonsky
Joseph Adkins‐Jablonsky
ALAlexander Tate Lasher
Alexander Tate Lasher
APAmit Patki
Amit Patki
ANAkash Nagarajan
Akash Nagarajan
LSLiou Y. Sun
Liou Y. Sun
Growth hormone‐releasing hormone‐deficient (GHRH‐KO) mice have previously been characterized by lower body weight, disproportionately high body fat accumulation, preferential metabolism of lipids compared to carbohydrates, improved insulin sensitivity, and an extended lifespan. That these mice are long‐lived and insulin‐sensitive conflicts with the notion that adipose tissue accumulation drives the health detriments associated with obesity (i.e., diabetes), and indicates that GH signaling may be necessary for the development of adverse effects linked to obesity. This prompts investigation into the ultimate effect of diet‐induced obesity on the lifespan of these long‐lived mice. To this end, we initiated high‐fat feeding in mid and late‐life in GHRH‐KO and wild‐type (WT) mice. We carried out extensive lifespan analysis coupled with glucose/insulin tolerance testing and indirect calorimetry to gauge the metabolic effect of high‐fat dietary stress through adulthood on these mice. We show that under high‐fat diet (HFD) conditions, GHRH‐KO mice display extended lifespans relative to WT controls. We also show that GHRH‐KO mice are more insulin‐sensitive and display less dramatic changes in their metabolism relative to WT mice, with GHRH‐KO mice fed HFD displaying respiratory exchange ratios and glucose oxidation rates comparable to control‐diet fed GHRH‐KO mice, while WT mice fed HFD showed significant reductions in these parameters. Our results indicate that GH deficiency protects against the adverse effects of diet‐induced obesity in later life.

4 September 2023 in Aging Cell
Verified
Journal Article
Open access
ALA. Tate Lasher
A. Tate Lasher
LSLiou Y. Sun
Liou Y. Sun
Our previous research has demonstrated that mice lacking functional growth hormone‐releasing hormone (GHRH) exhibit distinct physiological characteristics, including an extended lifespan, a preference for lipid utilization during rest, mild hypoglycemia, and heightened insulin sensitivity. They also show a further increase in lifespan when subjected to caloric restriction. These findings suggest a unique response to fasting, which motivated our current study on the response to glucagon, a key hormone released from the pancreas during fasting that regulates glucose levels, energy expenditure, and metabolism. Our study investigated the effects of an acute glucagon challenge on female GHRH knockout mice and revealed that they exhibit reduced glucose production, likely due to suppressed gluconeogenesis. However, these mice showed an increase in energy expenditure. We also observed alterations in pancreatic islet architecture, with smaller islets and a reduction of insulin‐producing beta cells but no changes in glucagon‐producing alpha cells. Additionally, the analysis of hepatic glucagon signaling showed a decrease in glucagon receptor expression and phosphorylated CREB. In conclusion, our findings suggest that the unique metabolic phenotype observed in these long‐lived mice may be partly explained by changes in glucagon signaling. Further exploration of this pathway may lead to new insights into the regulation of longevity in mammals.

29 May 2024 in Aging Cell
Verified
Journal Article
Open access
ALAlexander Tate Lasher
Alexander Tate Lasher
LWLiping Wang
Liping Wang
JHJooyoung Hyun
Jooyoung Hyun
SSScott A. Summers
Scott A. Summers
LSLiou Y. Sun
Liou Y. Sun
Dysregulation of growth hormone (GH) signaling consistently leads to increased lifespan in laboratory rodents, yet the precise mechanisms driving this extension remain unclear. Understanding the molecular underpinnings of the beneficial effects associated with GH deficiency could unveil novel therapeutic targets for promoting healthy aging and longevity. In our pursuit of identifying metabolites implicated in aging, we conducted an unbiased lipidomic analysis of serum samples from growth hormone‐releasing hormone knockout (GHRH‐KO) female mice and their littermate controls. Employing a targeted lipidomic approach, we specifically investigated ceramide levels in GHRH‐KO mice, a well‐established model of enhanced longevity. While younger GHRH‐KO mice did not exhibit notable differences in serum lipids, older counterparts demonstrated significant reductions in over one‐third of the evaluated lipids. In employing the same analysis in liver tissue, GHRH‐KO mice showed pronounced downregulation of numerous ceramides and hexosylceramides, which have been shown to elicit many of the tissue defects that accompany aging (e.g., insulin resistance, oxidative stress, and cell death). Additionally, gene expression analysis in the liver tissue of adult GHRH‐KO mice identified substantial decreases in several ceramide synthesis genes, indicating that these alterations are, at least in part, attributed to GHRH‐KO‐induced transcriptional changes. These findings provide the first evidence of disrupted ceramide metabolism in a long‐lived mammal. This study sheds light on the intricate connections between GH deficiency, ceramide levels, and the molecular mechanisms influencing lifespan extension.

20 November 2024 in Aging Cell
Verified
Journal Article
Open access
ALAlexander Tate Lasher
Alexander Tate Lasher
KLKaimao Liu
Kaimao Liu
MFMichael P Fitch
Michael P Fitch
LSLiou Y. Sun
Liou Y. Sun
Prior studies have shown that interrupting the growth hormone/insulin‐like growth factor‐I (GH/IGF‐I) signaling axis extends laboratory mouse lifespan, but confounding effects of additional gene or hormone deficiencies that exist in commonly used models of GH/IGF‐I interruption obscure the specific effect of GH on longevity. We address this issue by using mice with a specific knockout of the GH gene and show that both males and females on a mixed genetic background display extended lifespans resulting from GH deficiency. Our physiological assessment of these mice revealed that in addition to weighing significantly less and displaying significantly greater body fat (as a percentage of body weight), GH deficient mice display significant impairments in glucose metabolism and preferential fat utilization. These data provide strong evidence that GH deficiency is directly responsible for the altered nutrient utilization and extended lifespan that is commonly observed in mouse models of GH/IGF‐I interruption.